{"AllianceGenome": "8622", "HGNC": "8622", "MIM": "167415", "_id": "7849", "_version": 1, "accession": {"genomic": ["AC016683.7", "CH471217.1", "CP068276.2", "FJ695202.1", "KF459610.1", "NC_000002.12", "NC_060926.1", "NG_012384.1", "X99590.1"], "protein": ["AAA03539.1", "AAB34216.1", "AAB34217.2", "AAB34218.2", "AAH01060.1", "AAX88880.1", "AGN95866.1", "ALQ33862.1", "ALQ33863.1", "ALQ33864.1", "BAF84880.1", "CAA67903.1", "EAW73629.1", "EAW73630.1", "EAW73631.1", "EAW73632.1", "EAW73633.1", "EAW73634.1", "EAW73635.1", "EAW73636.1", "EAW73637.1", "EAW73638.1", "EAW73639.1", "NP_003457.1", "NP_039246.1", "NP_039247.1", "NP_054698.1", "Q06710.2"], "rna": ["AK023855.1", "AK096795.1", "AK124991.1", "AK225538.1", "AK292191.1", "AK307173.1", "AK309154.1", "AU141429.1", "BC001060.2", "BG398792.1", "BM726535.1", "CR936798.1", "KC733810.1", "KJ545852.1", "KJ545853.1", "KJ545855.1", "KJ545856.1", "KJ545857.1", "KJ545858.1", "KJ545859.1", "KJ545860.1", "KJ545861.1", "KJ545862.1", "KJ545863.1", "KJ545864.1", "KJ545867.1", "KJ545868.1", "KJ545869.1", "KJ545870.1", "KJ545871.1", "KJ545873.1", "KJ545875.1", "KJ545877.1", "KJ545883.1", "KJ545884.1", "KU178404.1", "KU178405.1", "KU178406.1", "L19606.1", "NM_003466.4", "NM_013951.3", "NM_013952.4", "NM_013953.4", "NM_013992.4", "S77904.1", "S77905.1", "S77906.2", "X69699.1"], "translation": [{"protein": "AGN95866.1", "rna": "KC733810.1"}, {"protein": "ALQ33864.1", "rna": "KU178406.1"}, {"protein": "AAH01060.1", "rna": "BC001060.2"}, {"protein": "AAB34216.1", "rna": "S77904.1"}, {"protein": "AAA03539.1", "rna": "L19606.1"}, {"protein": "NP_054698.1", "rna": "NM_013992.4"}, {"protein": "NP_039247.1", "rna": "NM_013953.4"}, {"protein": "NP_003457.1", "rna": "NM_003466.4"}, {"protein": "AAB34217.2", "rna": "S77905.1"}, {"protein": "ALQ33863.1", "rna": "KU178405.1"}, {"protein": "ALQ33862.1", "rna": "KU178404.1"}, {"protein": "BAF84880.1", "rna": "AK292191.1"}, {"protein": "AAB34218.2", "rna": "S77906.2"}, {"protein": "NP_039246.1", "rna": "NM_013952.4"}]}, "alias": "PAX-8", "ensembl": {"gene": "ENSG00000125618", "protein": ["ENSP00000263334", "ENSP00000263335", "ENSP00000314750", "ENSP00000380768", "ENSP00000395498", "ENSP00000451213", "ENSP00000451240", "ENSP00000451618", "ENSP00000452547", "ENSP00000505425"], "transcript": ["ENST00000263334", "ENST00000263335", "ENST00000348715", "ENST00000397647", "ENST00000429538", "ENST00000465084", "ENST00000467778", "ENST00000468980", "ENST00000480684", "ENST00000485840", "ENST00000497038", "ENST00000554352", "ENST00000554830", "ENST00000681162"], "translation": [{"protein": "ENSP00000263335", "rna": "ENST00000263335"}, {"protein": "ENSP00000314750", "rna": "ENST00000348715"}, {"protein": "ENSP00000380768", "rna": "ENST00000397647"}, {"protein": "ENSP00000263334", "rna": "ENST00000263334"}, {"protein": "ENSP00000395498", "rna": "ENST00000429538"}, {"protein": "ENSP00000505425", "rna": "ENST00000681162"}, {"protein": "ENSP00000451240", "rna": "ENST00000468980"}, {"protein": "ENSP00000452547", "rna": "ENST00000465084"}, {"protein": "ENSP00000451618", "rna": "ENST00000497038"}, {"protein": "ENSP00000451213", "rna": "ENST00000554830"}], "type_of_gene": "protein_coding"}, "entrezgene": "7849", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 16.0305014153, "exp_mis": 163.437496536, "exp_syn": 79.1248627012, "lof_z": 3.47127808708322, "mis_z": 0.514113582208453, "mu_lof": 1.24852422931e-06, "mu_mis": 1.659172616e-05, "mu_syn": 8.08333797432e-06, "n_lof": 2.0, "n_mis": 150.0, "n_syn": 90.0, "p_li": 0.90212384293593, "p_null": 3.53915662403427e-05, "p_rec": 0.0978407654978292, "syn_z": -0.757927711533633}, "bp": 1353, "cds_end": 114035971, "cds_start": 113976109, "n_exons": 11, "nonpsych": {"exp_lof": 14.3206727753, "exp_mis": 147.738231656, "exp_syn": 71.4271587655, "lof_z": 3.19745690169693, "mis_z": 0.404104767792402, "mu_lof": 1.24852422931e-06, "mu_mis": 1.659172616e-05, "mu_syn": 8.08333797432e-06, "n_lof": 2.0, "n_mis": 138.0, "n_syn": 78.0, "p_li": 0.847705343593016, "p_null": 0.000138353961090675, "p_rec": 0.152156302445894, "syn_z": -0.489648989188842}, "nontcga": {"exp_lof": 14.7296901425, "exp_mis": 150.344135787, "exp_syn": 72.776505764, "lof_z": 3.27191691096964, "mis_z": 0.623460617076139, "mu_lof": 1.24852422931e-06, "mu_mis": 1.659172616e-05, "mu_syn": 8.08333797432e-06, "n_lof": 2.0, "n_mis": 135.0, "n_syn": 86.0, "p_li": 0.855075827145928, "p_null": 9.91532560088277e-05, "p_rec": 0.144825019598063, "syn_z": -0.981460432432072}, "transcript": "ENST00000429538.3"}, "exons": [{"cdsend": 113278394, "cdsstart": 113218532, "chr": "2", "position": [[113215996, 113218609], [113220091, 113220178], [113227154, 113227256], [113235393, 113235582], [113236600, 113236721], [113241550, 113241726], [113242007, 113242130], [113242689, 113242778], [113244426, 113244624], [113246753, 113246919], [113278369, 113278469], [113278830, 113278921]], "strand": -1, "transcript": "NM_003466", "txend": 113278921, "txstart": 113215996}, {"cdsend": 113278394, "cdsstart": 113220091, "chr": "2", "position": [[113215996, 113218609], [113220091, 113220178], [113227154, 113227256], [113235393, 113235503], [113236600, 113236721], [113241550, 113241726], [113242007, 113242130], [113242689, 113242778], [113244426, 113244624], [113246753, 113246919], [113278369, 113278469], [113278830, 113278921]], "strand": -1, "transcript": "NM_013952", "txend": 113278921, "txstart": 113215996}, {"cdsend": 113278394, "cdsstart": 113220091, "chr": "2", "position": [[113215996, 113218609], [113220091, 113220178], [113227154, 113227256], [113241550, 113241726], [113242007, 113242130], [113242689, 113242778], [113244426, 113244624], [113246753, 113246919], [113278369, 113278469], [113278830, 113278921]], "strand": -1, "transcript": "NM_013953", "txend": 113278921, "txstart": 113215996}, {"cdsend": 113278394, "cdsstart": 113220091, "chr": "2", "position": [[113215996, 113218609], [113220091, 113220178], [113241550, 113241726], [113242007, 113242130], [113242689, 113242778], [113244426, 113244624], [113246753, 113246919], [113278369, 113278469], [113278830, 113278921]], "strand": -1, "transcript": "NM_013992", "txend": 113278921, "txstart": 113215996}], "exons_hg19": [{"cdsend": 114035971, "cdsstart": 113976109, "chr": "2", "position": [[113973573, 113976186], [113977668, 113977755], [113984731, 113984833], [113992970, 113993159], [113994177, 113994298], [113999127, 113999303], [113999584, 113999707], [114000266, 114000355], [114002003, 114002201], [114004330, 114004496], [114035946, 114036046], [114036407, 114036498]], "strand": -1, "transcript": "NM_003466", "txend": 114036498, "txstart": 113973573}, {"cdsend": 114035971, "cdsstart": 113977668, "chr": "2", "position": [[113973573, 113976186], [113977668, 113977755], [113984731, 113984833], [113992970, 113993080], [113994177, 113994298], [113999127, 113999303], [113999584, 113999707], [114000266, 114000355], [114002003, 114002201], [114004330, 114004496], [114035946, 114036046], [114036407, 114036498]], "strand": -1, "transcript": "NM_013952", "txend": 114036498, "txstart": 113973573}, {"cdsend": 114035971, "cdsstart": 113977668, "chr": "2", "position": [[113973573, 113976186], [113977668, 113977755], [113984731, 113984833], [113999127, 113999303], [113999584, 113999707], [114000266, 114000355], [114002003, 114002201], [114004330, 114004496], [114035946, 114036046], [114036407, 114036498]], "strand": -1, "transcript": "NM_013953", "txend": 114036498, "txstart": 113973573}, {"cdsend": 114035971, "cdsstart": 113977668, "chr": "2", "position": [[113973573, 113976186], [113977668, 113977755], [113999127, 113999303], [113999584, 113999707], [114000266, 114000355], [114002003, 114002201], [114004330, 114004496], [114035946, 114036046], [114036407, 114036498]], "strand": -1, "transcript": "NM_013992", "txend": 114036498, "txstart": 113973573}], "generif": [{"pubmed": 11923479, "text": "TTF-1 and Pax 8 cooperatively activate their target genes and their synergistic activity requires the cross-talk between enhancer and gene promoter"}, {"pubmed": 12161538, "text": "Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas."}, {"pubmed": 12441357, "text": "directly interacts with TTF-1 and synergistically activates transcription"}, {"pubmed": 12519876, "text": "Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas."}, {"pubmed": 12699588, "text": "transcription factor Pax-8 could be involved in the upregulation of D2 expression in the thyroid of Graves' patients"}, {"pubmed": 12727991, "text": "results suggest that conventional follicular thyroid carcinomas develop through at least two distinct molecular pathways initiated by either RAS point mutation or PAX8-peroxisome proliferator-activated receptor gamma rearrangement"}, {"pubmed": 12970322, "text": "lack of the PAX8/PPAR gamma rearrangement in the anaplastic thyroid carcinoma group suggests that the tumorigenic pathway in these tumors is likely to be independent of this fusion"}, {"pubmed": 15062550, "text": "Pax8 regulates the transcriptional activity of Hex promoter; several Pax8 binding sites in the Hex promoter are present"}, {"pubmed": 15355349, "text": "HNF1beta partially rescues Pax8/lim1-induced kidney malformations."}, {"pubmed": 15362967, "text": "the PAX8-PPARgamma1 translocation characterizes a subset of thyroid follicular carcinomas"}, {"pubmed": 15718293, "text": "A novel and unique PAX8 mutation provides evidence for a crucial role of the p300 coactivator in mediating the functional synergism between PAX8 and TTF-1 in thyroid-specific gene expression."}, {"pubmed": 15961562, "text": "in JAR cells, hCG activates a cAMP-dependent pathway that can up-regulate WT1 expression through PAX8"}, {"pubmed": 16029487, "text": "Pax8 may have a role in re-differentiation of thyroid cancer cells"}, {"pubmed": 16179407, "text": "PAX8-PPARgamma disrupts normal transcriptional regulation by stimulating some genes and inhibiting others, the net effect of which may mediate follicular thyroid cell growth and loss of differentiation."}, {"pubmed": 16219715, "text": "In follicular variant of papillary thyroid carcinoma, the PAX8-PPARgamma rearrangement was significantly associated with multifocality and vascular invasion"}, {"pubmed": 16352687, "text": "Suppression of NORE1A, a known Ras effector, in PAX8-PPARgamma fusion-carrying follicular thyroid cancer."}, {"pubmed": 16613988, "text": "Oligomerization chain reaction (OCR) strategy allows identification of Foxe1, TTF-1, and thyroid oxidase 2 as new direct targets of Pax8."}, {"pubmed": 16763387, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16814811, "text": "Results showed no direct involvement of PAX-2 genes in Wilms tumor pathogenesis."}, {"pubmed": 17064757, "text": "PAX8 is expressed in ovarian cancer but not in the precursor ovarian surface epithelia of healthy individuals. PAX8 is expressed in the non-ciliated, secretory cells of healthy fallopian tube mucosal linings but not in the adjacent ciliated epithelia."}, {"pubmed": 17437516, "text": "PAX8 mutations in congenital hypothyroidism due to dysgenetic or orthotopic thyroid glands are rare. PAX8-T225M is probably a rare variant."}, {"pubmed": 17468187, "text": "identification of a novel PAX8 mutation in a particular variant of non-congenital early-onset hypothyroidism indicates a key function of PAX8 in the postnatal growth and functional maintenance of the thyroid gland"}, {"pubmed": 17614769, "text": "PAX8PPARgamma increases thyroid cell viability and has opposite effects on thyroid-specific gene expression, suggesting that the presence of this rearrangement may contribute to the malignant transformation of thyroid follicular cells."}, {"pubmed": 17980011, "text": "We report the occurrence of one novel (p.G336S), and two novel synonymous substitutions (p.L233L and p.A439A) in the PAX8 gene"}, {"pubmed": 18084247, "text": "Pax8 is a useful marker for the diagnosis of anaplastic carcinomas."}, {"pubmed": 18632625, "text": "PAX8 binds directly to the hTERT and hTR promoters, up-regulating hTERT and hTR mRNA, as well as telomerase activity"}, {"pubmed": 18670350, "text": "PAX8 is an additional marker for identifying nephrogenic adenoma"}, {"pubmed": 18724243, "text": "Pax8 is a useful marker in the differential diagnosis of ovarian and breast carcinomas."}, {"pubmed": 18768662, "text": "Results suggest that PARP1 behaves as an important negative co-factor involved in the regulation of Pax8-dependent gene expression."}, {"pubmed": 18829450, "text": "Pax-8 activity is regulated via a redox-based mechanism centered on the glutathionylation of specific cysteines in the N-terminal region (Cys45 and Cys57)."}, {"pubmed": 18974227, "text": "Data show that Pax8 is targeted in the SUMO nuclear bodies, and that the steady-state protein level of Pax8 is controlled by sumoylation."}, {"pubmed": 18976153, "text": "Clinical analysis revealed distinct hormonal patterns in thyroid hypoplasia when compared with other variants of thyroid dysgenesis, with genetic abnormalities identified only in few cases in the TSH-R, PAX8, and NKX2.5 genes."}, {"pubmed": 19525927, "text": "PAX8 may be a useful additional marker for renal epithelial tumors"}, {"pubmed": 19730683, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19797117, "text": "Pax8-PPARG fusion protein and Pten synergistically cause thyroid hyperplasia in transgenic mice."}, {"pubmed": 19963130, "text": "It is hereby concluded that 3p25 aneusomy or PAX8-PPARG translocation may play an important role in the molecular pathogenesis of follicular thyroid tumors"}, {"pubmed": 20157192, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20302910, "text": "genetics and phenomics of hypothyroidism and thyroid dysgenesis due to PAX8 mutations (Review)"}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20414099, "text": "PAX8 may also be a prognostic marker in pancreatic endocrine tumors, as loss of expression is associated with malignant behavior."}, {"pubmed": 20463571, "text": "We propose the use of the combination of PAX8 and p63 in the diagnosis of poorly differentiated renal sinus epithelial neoplasms where the differential diagnosis includes collecting duct carcinoma versus upper urinary tract urothelial carcinoma."}, {"pubmed": 20470391, "text": "a thyroid-specific regulatory element in the 5' upstream region of the Pax8 gene"}, {"pubmed": 20492080, "text": "PAX8 expression is a useful marker that effectively discriminated metastatic ovarian carcinomas from metastatic breast carcinomas and primary adnexal tumors."}, {"pubmed": 20513481, "text": "The combined use of MS procedures and protein-functional assays to investigate the redox state of a protein-regulating gene expression in thyroid, namely Pax-8, a member of the Pax family of transcription factors."}, {"pubmed": 20572292, "text": "Data show that PAX8 was found to be positive in 37 of 41 (90%) ovarian carcinoma cases studied, and was a sensitive (90%) and specific (100%) marker for the detection of metastatic ovarian carcinoma."}, {"pubmed": 20607683, "text": "our findings suggest that PAX8 is an additional marker for carcinomas of Mullerian origin"}, {"pubmed": 20634891, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20667985, "text": "A physical interaction was observed between the NF-kappaB p65 subunit and paired box 8 (Pax8), which appears to be responsible for the synergic effect displayed by these transcription factors on NIS gene transcription."}, {"pubmed": 20718765, "text": "Findings confirm the important role of PAX8 in normal thyroid development and support the evidence that in humans haploinsufficiency of PAX8 is associated with thyroid dysgenesis."}, {"pubmed": 20851479, "text": "The Pax-8 gene may play a crucial role in heart development and regulating cardiocyte apoptosis and knockout of Pax-8 may exert a similar effect on myocardial morphology and apoptosis as those seen in ALK3 knockouts."}, {"pubmed": 20857061, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20857061, "text": "no mutation in PAX8 gene is responsible for the thyroid dysgenesis in this cohort of Iranian congenital hypothyroidism patients."}, {"pubmed": 21263247, "text": "The PAX2(-), PAX8(-), and inhibin A(+) profile supports the diagnosis of hemangioblastoma with a sensitivity of 95%, specificity of 100%, and positive predictive value of 100%."}, {"pubmed": 21289264, "text": "EZH2 is specifically overexpressed in ATC, and it directly contributes to transcriptional silencing of PAX8 gene and anaplastic thyroid carcinoma differentiation."}, {"pubmed": 21317881, "text": "PAX 8 is a sensitive and specific marker for tumors of renal, Mullerian, or thyroid origin in both primary and metastatic sites."}, {"pubmed": 21328566, "text": "PAX8 expression in poorly differentiated neuroendocrine carcinomas is not specific for pancreatic origin and can be seen in extrapancreatic poorly differentiated neuroendocrine carcinomas"}, {"pubmed": 21552115, "text": "PAX8 is an excellent marker for confirming primary tumor site."}, {"pubmed": 21602887, "text": "results suggest that, in cancer, frequent and persistent expression of PAX8 is required for cell growth control through transcriptional activation of E2F1 expression and upregulation of the RB-E2F1 pathway"}, {"pubmed": 21606823, "text": "Distinctive immunohistochemical expression of PAX8 and lack of prostate-specific antigen can help in distinguishing this benign entity from prostatic adenocarcinoma."}, {"pubmed": 21663937, "text": "PAX8 expression is often retained in anaplastic thyroid carcinomas including the squamoid variant, but it is not expressed in head and neck squamous cancers."}, {"pubmed": 21689132, "text": "The relationship between mutations of PAX8 and congenital hypothyroidism in the Mexican population is studied."}, {"pubmed": 21763631, "text": "have quantified the HMGA2 mRNA level, which was not elevated in the two adenomas with the PAX8- PPARG fusion, compared to histologically normal thyroid tissue"}, {"pubmed": 21836478, "text": "Report pPx8 in a series of thymic epithelial neoplasms."}, {"pubmed": 21836481, "text": "Diffuse expression of PAX2 and PAX8 in the cystic epithelium of mixed epithelial stromal tumor, angiomyolipoma with epithelial cysts, and primary renal synovial sarcoma supports renal tubular differentiation."}, {"pubmed": 21838611, "text": "Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung."}, {"pubmed": 21932072, "text": "Pax8 is not expressed in the pancreas and cast doubts on the value of Pax8 as a pancreatic neuroendocrine tumor marker."}, {"pubmed": 21934480, "text": "PAX8 and PAX2 IHC may facilitate the diagnosis of primary epithelial neoplasms of the male genital tract."}, {"pubmed": 21979593, "text": "PAX 8 overexpression correlates with p53 expression and high-grade endometrial carcinomas but seems not to be useful as a prognostic parameter."}, {"pubmed": 21989345, "text": "PAX8 supersedes PAX2 as probably the best epithelial marker hitherto for primary or metastatic mullerian epithelial tumors."}, {"pubmed": 22037256, "text": "our data indicate that PAX8 is not expressed in benign or malignant B-cells"}, {"pubmed": 22135028, "text": "PAX8 is expressed in the majority of renal epithelial neoplasms and is a valuable marker for nephric neoplasms."}, {"pubmed": 22261458, "text": "PAX8 and WT1 had comparable overall detection rates in confirming ovarian origin of malignant effusion."}, {"pubmed": 22293317, "text": "Heterozygous missense mutation and a variation in PAX8 are associated with congenital hypothyroidism."}, {"pubmed": 22388755, "text": "Both Islet 1 and PAX8 are reliable immunohistochemical markers for identifying metastatic neuroendocrine tumors of pancreatic origin."}, {"pubmed": 22495365, "text": "PAX-2, PAX-8, and hKIM-1 should be used cautiously in distinguishing renal cell carcinoma from nonseminomatous germ cell neoplasia and also adds to the growing list of nonrenal tumors that express these 3 markers."}, {"pubmed": 22644304, "text": "A positive association of Pax8(+) expression was found with high tumour grade (P=0.002), LVI+(P=0.0186), and type II tumour subtype (P<0.0001) in univariate analysis."}, {"pubmed": 22666732, "text": "Absence of mutations in PAX8, NKX2.5, and TSH receptor genes demonstrate the rare genetic etiology in sporadic cases of thyroid dysgenesis."}, {"pubmed": 22705448, "text": "PAX8 was expressed in 61% of cases. There was no association between PAX8 and tumor stage, optimal debulking and disease recurrence for ovarian serous carcinoma."}, {"pubmed": 22807381, "text": "PAX8 and PAX2 are diagnostically useful adjuncts in confirming the diagnosis of renal cell carcinoma in cytology specimens."}, {"pubmed": 22898500, "text": "clinical and molecular findings of 4 novel PAX8 mutations, including 3 missense mutations outside the previously recognized mutational hotspot and the first experimentally confirmed mutation with protein instability (D46fs); data imply PAX8 haploinsufficiency is enough to cause congenital hypothyroidism"}, {"pubmed": 22961909, "text": "pathogenic role played by PAX8-PPARG fusion genes in thyroid tumorigenesis."}, {"pubmed": 23163626, "text": "The purpose of this study was to evaluate the expression patterns of B-cell specific activator protein (BSAP)/PAX5 and PAX8 in a wide variety of B-cell and T-cell neoplasms"}, {"pubmed": 23194047, "text": "investigation of expression of PAX2 and PAX8 in renal biopsy samples as diagnostic markers in the differential diagnosis of various types of primary and secondary renal cell carcinomas"}, {"pubmed": 23196794, "text": "PAX8 and claudin-4 have a higher sensitivity and specificity for assisting in discriminating between peritoneal epithelioid mesotheliomas and serous carcinomas when compared with all of the other positive carcinoma markers"}, {"pubmed": 23202787, "text": "we sought to investigate the immunohistochemical expression of PAX8 and PAX2 in cervical adenocarcinoma in situ and high-grade squamous intraepithelial lesions"}, {"pubmed": 23218904, "text": "In summary, the panel of RCC Ma, Pax8, brachyury, and SF-1 is useful in the differential diagnosis of tumors with clear morphology."}, {"pubmed": 23308388, "text": "study describes and characterizes two new PAX8 gene mutations in patients with thyroid dysgenesis. The mutations have different pathogenic mechanisms by which they are causative."}, {"pubmed": 23328975, "text": "Immunostains for PAX2 and PAX8 are useful in the detection of nephrogenic adenomas and particularly unveil those nephrogenic adenomas with flat pattern."}, {"pubmed": 23436219, "text": "Results provide the first demonstration of PAX8/PPARgamma rearrangements in post-Chernobyl tumors and show different associations for point mutations and chromosomal rearrangements with (131) I dose and other factors."}, {"pubmed": 23453625, "text": "PAX8 can be used to distinguish sarcomatoid renal cell carcinoma from atypical epithelioid epithelioid angiomyolipomas and primary renal or retroperitoneal sarcomas."}, {"pubmed": 23503645, "text": "claudin-4 and PAX8 have a higher sensitivity and specificity for discriminating between pleural epithelioid mesotheliomas and renal cell carcinomas compared with other positive carcinoma markers"}, {"pubmed": 23550799, "text": "Mullerian and eccrine cutaneous ciliated cysts: two different entities? The contribution of WT-1 and PAX8 to diagnosis."}, {"pubmed": 23612030, "text": "PAX-8 staining in Merkel cell carcinoma expands the spectrum of tumors showing immunoreactivity and may prove to be a useful addition to a diagnostic panel."}, {"pubmed": 23647375, "text": "Case Report: novel PAX8 mutation is responsible for a severe form of dominantly inherited congenital hypothyroidism. The mutation seems to be associated with abnormalities of the urogenital tract."}, {"pubmed": 23738683, "text": "There was no correlation between the extent of capsular or vascular invasion and PAX8-PPARgamma translocation, or between lymph node or haematogenous metastasis and PAX8-PPARgamma translocation in thyroid carcinomas."}, {"pubmed": 23787439, "text": "The differential expression of PAX8 and TTF-1 may prove useful in distinguishing between neuroendocrine carcinomas of pulmonary and thymic origin"}, {"pubmed": 23811186, "text": "Data suggest that PAX8 (detected in fine-needle aspirates of thyroid gland tumor tissue using immunocytochemistry) can serve as a tumor marker for diagnosis of anaplastic thyroid carcinoma. [CASE REPORT; 3 adult subjects]"}, {"pubmed": 23958394, "text": "PAX8 is a sensitive marker to diagnose the carcinomas of ovarian origin, which will be ideal to be used for those patients with a possible advanced ovarian cancer prior to receiving neoadjuvant chemotherapy."}, {"pubmed": 23958552, "text": "useful in distinguishing thymic carcinoma from poorly differentiated lung carcinoma"}, {"pubmed": 24037217, "text": "We have demonstrated that Islet 1 and PAX8 are not entirely specific for neuroendocrine tumors of pancreatic origin, as they are expressed in a majority of rectal neuroendocrine tumors."}, {"pubmed": 24086368, "text": "A significant interaction between variants in STK17B and PAX8, in papillary thyroid cancer susceptibility, is reported."}, {"pubmed": 24225756, "text": "PAX8 may have some use in suggesting a cervical or urothelial tract origin in a metastatic squamotransitional carcinoma of unknown primary"}, {"pubmed": 24334997, "text": "PAX2 and PAX8 are valuable diagnostic markers for metastatic mullerian carcinomas and renal cell carcinoma in effusion cytology"}, {"pubmed": 24340305, "text": "we show for the first time that the novel insert in exon two of the PAX8 protein might be associated with congenital thyroid hemiagenesis and influence development of different types of cancer"}, {"pubmed": 24602166, "text": "PAX8 is increased in the majority of glioblastomas and promoted cell survival."}, {"pubmed": 24628993, "text": "Data shows that PAX8 provides signals for growth and motility of non-small cell lung cancer cells and is necessary for MET and RON expression."}, {"pubmed": 24766781, "text": "our results indicate that PAX8 plays an important role in the tumorigenic phenotype of ovarian cancer cells and identifies PAX8 as a potential new target for the treatment of ovarian cancer."}, {"pubmed": 24798894, "text": "In this series, PAX8/PPARgamma rearrangement found in thyroid nodules had a 100% predictive value for differentiated thyroid cancer"}, {"pubmed": 24857336, "text": "We reviewed the reliability of PAX8 to determine tumor type or primary site in 135 current clinical pelvic or abdominal lesions"}, {"pubmed": 24897005, "text": "PAX8 immunoexpression was noticed in five and three cases of alveolar rhabdomyosarcomas and embryonal rhabdomyosarcomas, respectively. About one-third of malignant rhabdoid tumors were PAX2-positive and PAX8-positive."}, {"pubmed": 24901404, "text": "PAX8 is expressed in the carcinomatous components of nearly all uterine malignant mesodermal mixed tumors, with expression in sarcomatous and undifferentiated components being less common and less extensive."}, {"pubmed": 24992169, "text": "PAX2 and PAX8 are useful biomarker in the differential diagnosis of ovarian serous and mucinous tumors"}, {"pubmed": 25083965, "text": "PAX8 is expressed in the vast majority of uterine adenocarcinomas, and that the level of expression based on combined extent and intensity is highest in endometrial serous carcinoma and lowest in endocervical adenocarcinoma."}, {"pubmed": 25146893, "text": "R133W-PAX8 variant is associated with phenotype ranging from congenital hypothyroidism with thyroid hypoplasia to mild subclinical hypothyroidism."}, {"pubmed": 25153494, "text": "immunohistochemical marker, which allows to differentiate seminal vesicle from prostate gland epithelium in prostate needle biopsies"}, {"pubmed": 25214233, "text": "The novel p.I47T PAX8 mutation presented loss of function leading to Congenital Hypothyroidism (CH)."}, {"pubmed": 25270402, "text": "The 5'-flanking region of the Wnt4 gene is responsive to Pax8. Pax8 modulates the expression of Wnt4 in thyroid cells."}, {"pubmed": 25279712, "text": "Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin."}, {"pubmed": 25287489, "text": "PAX8 protein expression was associated with germinal layers in forebrain and hindbrain development...and PAX8 expression is linked to better prognosis in medulloblastomas"}, {"pubmed": 25315900, "text": "This study confirms that PAX-8 expression is a useful diagnostic marker for renal cell carcinoma"}, {"pubmed": 25433656, "text": "PAX6 and PAX8 positivity was seen in of metastatic pancreatic neuroendocrine tumors to the liver"}, {"pubmed": 25708358, "text": "we examined PAX8-PPARgamma rearrangement in 24 follicular thyroid carcinoma samples from Japanese patients. The fusion gene was detected in only one of 24 follicular thyroid carcinomas (4%)."}, {"pubmed": 25720050, "text": "Heterozygous transition in exon 3 of PAX8 gene is associated with hyroid hypoplasia."}, {"pubmed": 25827135, "text": "PAX8 (mAb) was a specific marker in differentiating primary and extragenital metastatic mucinous ovarian tumours."}, {"pubmed": 26030152, "text": "the novel interplay between PAX8 and Neuropilin-2"}, {"pubmed": 26079312, "text": "PAX8 is frequently expressed by ovarian surface epithelial cells, and endogenous levels of PAX8 expression are non-transforming."}, {"pubmed": 26258321, "text": "Compared with RAS or PAX8/PPARG-positive TCs, BRAFV600E or RET/PTC-positive Thyroid cancers were more often associated with stage III/IV disease and recurrence."}, {"pubmed": 26282166, "text": "miR-146b-3p binds to the 3'-untranslated region of PAX8 and sodium/iodide symporter. miR-146b and PAX8 regulate each other and share common target genes."}, {"pubmed": 26352548, "text": "rete ovarii were positive for PAX-8, weakly positive for SF-1, and negative for PAX-2 and GATA-3"}, {"pubmed": 26354716, "text": "PAX8 staining is useful for distinguishing between primary thyroid squamous cell carcinoma and invasion or metastasis from extrathyroidal squamous cell carcinoma."}, {"pubmed": 26362610, "text": "PAX8 mutation rate among congenital hypothyroidism patients"}, {"pubmed": 26370671, "text": "High Levels of mRNA of both PAX8 are associated with benign than in malignant thyroid lesions."}, {"pubmed": 26371431, "text": "results indicate that presence of PAX8 immunoreactivity in an undifferentiated brain tumor lacking gliofibrillary acidic protein expression should prompt consideration of a metastatic tumor"}, {"pubmed": 26404914, "text": "a substantial minority of solitary fibrous tumors express nuclear PAX8 and PAX2"}, {"pubmed": 26617871, "text": "showing that the PAX8 mutation rate is very low in thyroid dysgenesis patients in China"}, {"pubmed": 26797858, "text": "PAX2, PAX8, CDX2 immunostains was preformed to the TMA slides."}, {"pubmed": 26910219, "text": "PAX8 is expressed in the majority of benign, premalignant, and malignant endocervical glandular lesions."}, {"pubmed": 27129161, "text": "PAX8 has a cell specific role in governing proliferation and migration in nontransformed ovarian surface epithelium cells compared to the oviductal cells, but its reduction in serous cancer cell lines provides a common mechanism for reducing cell survival."}, {"pubmed": 27175788, "text": "This is the first report of PAX8 aberrant transcript production in cervical cancer. Reported PAX8 isoforms possess differential transactivation properties; therefore, besides being a helpful marker for detection of cancer, PAX8 isoforms can plausibly exert differential regulation properties during carcinogenesis"}, {"pubmed": 27207603, "text": "Direct sequencing of the PAX8 gene revealed a novel single nucleotide substitution (c.162 A>T) in exon 2 that resulted in the substitution of the normal serine 54 with a cysteine (S54C), which segregated with elevated serum TSH levels."}, {"pubmed": 27225188, "text": "Study suggested that PAX8 eQTLs SNPs (rs4848320 and rs1110839) located in lncRNA PAX8-AS1 might predict decreased risk of cervical cancer."}, {"pubmed": 27249794, "text": "findings point to significant PTC-associated dysregulation of several PAX8 target genes, supporting the notion that PAX8-regulated molecular cascades play important roles during thyroid tumorigenesis"}, {"pubmed": 27259239, "text": "Data suggest that candidate genes and pathways regulated by PAX8 that could be additional targets for the therapy of ovarian carcinoma."}, {"pubmed": 27362905, "text": "We conclude that PAX8 immunostain is negative in most cervical cell carcinomas and is less frequently expressed in endocervical adenocarcinomas as compared with the previously reported high sensitivity for ovarian and endometrial adenocarcinomas"}, {"pubmed": 27494321, "text": "we replicated one known signal in PAX8 (2.6 minutes per allele, 95% CI [1.9, 3.2], P = 5.7x10-16) and identified and replicated two novel associations at VRK2 (2.0 minutes per allele, 95% CI [1.3, 2.7], P = 1.2x10-9; and 1.6 minutes per allele, 95% CI [1.1, 2.2], P = 7.6x10-9)"}, {"pubmed": 27573549, "text": "Study postulated that both TTF-1 and PAX-8 when co-expressed and have anti-proliferative and anti-tumorigenic properties up to a threshold expression level and beyond that, are able to induce pro-tumorigenic effects in thyroid carcinomas."}, {"pubmed": 27761900, "text": "PAX8 was negative in all cases of pulmonary neuroendocrine carcinoma (PNEC) while positive in 86.4% of thymic cases (TNEC). TTF-1 positivity was associated with high sensitivity but low specificity for PNEC, and adding PAX8 negativity significantly increased the specificity. PAX8 positivity alone showed essentially 100% specificity and 86.4% sensitivity for TNEC."}, {"pubmed": 27797226, "text": "Pax8 gene Rearrangement is associated with Breast Cancer."}, {"pubmed": 28060725, "text": "Identify several novel PAX8 mutations in congenital hypothyroidism patients that impair the binding or activating abilities of PAX8 at the promoters of the target genes thyroglobulin and thyroperoxidase."}, {"pubmed": 28103614, "text": "Putative PAX8 target genes are enriched for common serous epithelial ovarian cancer risk variants."}, {"pubmed": 28248726, "text": "PAX8-positive Biphasic Synovial Sarcoma Expressing Hormonal Receptors."}, {"pubmed": 28322461, "text": "findings proved that iodinated TG in thyroid follicular lumen regulated TTF-1 and PAX8 expression through thyroid stimulating hormone/thyroid stimulating hormone receptor (TSH/TSHR) mediated cAMP-PKA and PLC-PKC signaling pathways."}, {"pubmed": 28339471, "text": "Although the exact biological function remains to be explored, our findings suggest a possible association of PAX8eQTLs in lncRNA AC016683.6 with the hepatocellular carcinoma prognosis in the Chinese population."}, {"pubmed": 28367736, "text": "In an Asian setting, PAX8 and WT1 are expressed in the vast majority of serous ovarian cancers and may be useful in distinguishing serous ovarian carcinomas from other poorly differentiated tumours."}, {"pubmed": 28426529, "text": "Diagnostic Utility of Pax8, Pax2, and NGFR Immunohistochemical Expression in Pediatric Renal Tumors."}, {"pubmed": 28506732, "text": "Case Report: primary seminal vesicle carcinoma strong and diffuse nuclear labeling for PAX8."}, {"pubmed": 28621837, "text": "PAX8-PPARG fusions may not play major roles in the tumorigenesis of paediatric follicular thyroid carcinoma."}, {"pubmed": 28749793, "text": "the relatively frequent expression of PAX8 by SFT and STAT6 expression in liposarcoma. PAX8 expression by a spindle cell lesion of RP would not allow distinction between SFT, SRCC, or sclerosing liposarcoma by itself. A STAT6/PAX8 phenotype excludes SRCC."}, {"pubmed": 28777151, "text": "this study shows that PAX-8 positivity is rare in primary lung carcinoma"}, {"pubmed": 28877056, "text": "PAX8 is expressed in both benign and malignant mesothelium, and that BAP1 loss is highly specific for malignant peritoneal neoplasms, in the differential with both benign mesothelial proliferations and ovarian serous tumors."}, {"pubmed": 29379162, "text": "PAX8 positively regulates the expression of TP53 in high grade serous ovarian carcinoma (HGSC) and the pro-proliferative role of PAX8 is mediated by the gain of function activity of mutant p53. Surprisingly, mutant p53 transcriptionally activates the expression of p21, which localizes to the cytoplasm of HGSC cells where it plays a non-canonical, pro-proliferative role."}, {"pubmed": 29629948, "text": "PAX8 negativity is not as specific for cerebellar hemangioblastoma"}, {"pubmed": 30358609, "text": "these results indicate a significant fraction of breast carcinoma metastases and corresponding primary neoplasms have immunoreactivity for PAX8, and positivity rates depend on the antibody used."}, {"pubmed": 30639194, "text": "LINC00958 may bind to miR-330-5p to inhibit PAX8 in a competitive fashion, thereby preventing the progression of pancreatic cancer."}, {"pubmed": 30648929, "text": "GLIS rearrangements, particularly PAX8-GLIS3, are highly prevalent in hyalinizing trabecular but not in papillary thyroid carcinoma"}, {"pubmed": 30720110, "text": "Expression levels of PAX8AS1:28 and PAX8 were lower in papillary thyroid carcinoma (PTC) tissue and PTC cells than those in healthy tissue and cells. Expression level of MYC was higher in PTC cells than that in normal cells. PAX8AS1:28 silencing reduced the expression level of PAX8 and promoted tumor cell growth, while PAX8AS1:28 overexpression increased the expression level of PAX8 and inhibited tumor cell growth."}, {"pubmed": 30789354, "text": "Primary Renal Synovial Sarcomas: PAX 8 Immunostaining and Unusual Molecular Findings."}, {"pubmed": 31050342, "text": "hese findings provide mechanistic and therapeutic insights for PAX8-addicted ovarian cancer. More generally, our analytic and experimental approach represents an expandible paradigm for identifying and targeting lineage-survival oncogenes in diverse human malignancies."}, {"pubmed": 31273314, "text": "PAX8-GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid."}, {"pubmed": 31335489, "text": "Comparison of PAX8 Expression in Breast Carcinoma Using MRQ50 and BC12 Monoclonal Antibodies."}, {"pubmed": 31353958, "text": "combined SOX13 and PAX8 expression regulate the proliferation of gastric cancer cells"}, {"pubmed": 31391550, "text": "HBx stabilizes PAX8 protein by inhibiting the Skp2 targeted PAX8 ubiquitination and enhancing the Aurora A-mediated its phosphorylation, contributing to the progression of hepatoma"}, {"pubmed": 31431624, "text": "The data identifies PAX8 as a candidate oncogene in Renal Cell Carcinoma and provides a potential biomarker to monitor its activity."}, {"pubmed": 31558562, "text": "Their effects on Pax8 and Bcl2 were rescued by Klhl14-AS overexpression."}, {"pubmed": 31932679, "text": "PAX8 expression and TERT promoter mutations in the nested variant of urothelial carcinoma: a clinicopathologic study with immunohistochemical and molecular correlates."}, {"pubmed": 31932920, "text": "immunophenotyping with CLDN18, CDH17, and PAX8 might improve the diagnostic accuracy of histopathological classifications of endocervical adenocarcinoma"}, {"pubmed": 32096550, "text": "Genetic testing of PAX8 mutations associated with thyroid dysgenesis in Chinese congenital hypothyroidism patients."}, {"pubmed": 32332753, "text": "Study identified non-coding elements that may contribute to ovarian cancer (OC) development. Many of the mutated regulatory elements and their associated genes provide insights into disease pathogenesis, and the lineage-specific transcription factor PAX8 was identified a central player in the transcriptional dysregulation caused by non-coding somatic mutations in high-grade serous OCs."}, {"pubmed": 32381599, "text": "Pax2 and Pax8 Proteins Regulate Urea Transporters and Aquaporins to Control Urine Concentration in the Adult Kidney."}, {"pubmed": 32383186, "text": "Oncogenic properties and signaling basis of the PAX8-GLIS3 fusion gene."}, {"pubmed": 32430717, "text": "PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis."}, {"pubmed": 32841355, "text": "Congenital Hypothyroidism Due to Truncating PAX8 Mutations: A Case Series and Molecular Function Studies."}, {"pubmed": 32988924, "text": "Characterization of Paired Box 8 (PAX8)-expressing Metastatic Breast Carcinoma."}, {"pubmed": 33002562, "text": "Usefulness of PAX8 Immunohistochemistry in Adult Intraocular Tumor Diagnosis."}, {"pubmed": 33208672, "text": "PAX8 Expression in Breast Cancer."}, {"pubmed": 33361393, "text": "Unraveling the Mysteries of PAX8 in Reproductive Tract Cancers."}, {"pubmed": 33434492, "text": "Perturbations of genes essential for Mullerian duct and Wolffian duct development in Mayer-Rokitansky-Kuster-Hauser syndrome."}, {"pubmed": 33566340, "text": "Monoclonal/polyclonal PAX-8, PTH and GATA3 immunohistochemistry in parathyroid lesions."}, {"pubmed": 33794208, "text": "Genetic variation in cervical preinvasive and invasive disease: a genome-wide association study."}, {"pubmed": 33830648, "text": "Adipose-derived mesenchymal stem cells induced PAX8 promotes ovarian cancer cell growth by stabilizing TAZ protein."}, {"pubmed": 33852846, "text": "Single-cell transcriptomics identifies gene expression networks driving differentiation and tumorigenesis in the human fallopian tube."}, {"pubmed": 33862642, "text": "Genetic Variability of the Paired Box Transcription Factor; PAX8 Gene: Guidance Towards Treatment Strategies in a Cohort of Congenital Hypothyroidism."}, {"pubmed": 33903593, "text": "PAX8 and MECOM are interaction partners driving ovarian cancer."}, {"pubmed": 34081633, "text": "PAX-8 Expression in Salivary Duct Carcinoma."}, {"pubmed": 34102541, "text": "Polyclonal PAX8 expression in carcinomas of the biliary tract - Frequent non-specific staining represents a potential diagnostic pitfall."}, {"pubmed": 34145460, "text": "PAX8/PAX8-AS1 DNA methylation levels are associated with objective sleep duration in persons with unexplained hypersomnolence using a deep phenotyping approach."}, {"pubmed": 34244607, "text": "PAX8 plays an essential antiapoptotic role in uterine serous papillary cancer."}, {"pubmed": 34290299, "text": "PAX8 lineage-driven T cell engaging antibody for the treatment of high-grade serous ovarian cancer."}, {"pubmed": 34339032, "text": "PAX8, an Emerging Player in Ovarian Cancer."}, {"pubmed": 35124696, "text": "SOX17 and PAX8 constitute an actionable lineage-survival transcriptional complex in ovarian cancer."}, {"pubmed": 35154515, "text": "hsa_circ_0139402 Promotes Bladder Cancer Progression by Regulating hsa-miR-326/PAX8 Signaling."}, {"pubmed": 35185017, "text": "A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary."}, {"pubmed": 35209928, "text": "MiR-326 inhibits trophoblast growth, migration, and invasion by targeting PAX8 via Hippo pathway."}, {"pubmed": 35380877, "text": "The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17."}, {"pubmed": 35387670, "text": "PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis."}, {"pubmed": 35417734, "text": "Unusual staining of immunohistochemical markers PAX8 and CDX2 in breast carcinoma: a potential diagnostic pitfall."}, {"pubmed": 35676472, "text": "The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer."}, {"pubmed": 35713353, "text": "Oncogenic Signaling in Kidney Cancer Requires Renal Lineage Factor PAX8."}, {"pubmed": 35926290, "text": "The utility of PAX8 in comparison with PAX5 immunohistochemical staining in the diagnosis of Hodgkin lymphoma."}, {"pubmed": 36281161, "text": "Significance analysis of PAX8 expression in endometrial carcinoma."}, {"pubmed": 36730878, "text": "Two Cases of Biphasic Synovial Sarcoma With Expression of PAX8 and ER: A Diagnostic Pitfall."}, {"pubmed": 36731037, "text": "Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2, Cyclin D1, SALL4, and BCOR in High-grade Endometrial Carcinomas."}, {"pubmed": 38272482, "text": "Initial screening of the rs104893657 variant of the PAX8 gene in women with hypothyroidism from Northeastern Slovakia."}, {"pubmed": 38677751, "text": "Diagnostic Value of Immunostaining for Thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (PAX8) in Distinguishing Pulmonary Metastases of Mesonephric and Mesonephric-like Adenocarcinomas from Primary Lung Adenocarcinomas."}, {"pubmed": 38993572, "text": "METTL3 regulates thyroid cancer differentiation and chemosensitivity by modulating PAX8."}], "genomic_pos": {"chr": "2", "end": 113278921, "ensemblgene": "ENSG00000125618", "start": 113215997, "strand": -1}, "genomic_pos_hg19": {"chr": "2", "end": 114036527, "start": 113973574, "strand": -1}, "go": {"BP": [{"evidence": "ISS", "gocategory": "BP", "id": "GO:0001655", "qualifier": "involved_in", "term": "urogenital system development"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0001658", "pubmed": 1337742, "qualifier": "involved_in", "term": "branching involved in ureteric bud morphogenesis"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0001822", "pubmed": 15494458, "qualifier": "involved_in", "term": "kidney development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0001823", "qualifier": "involved_in", "term": "mesonephros development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0003281", "qualifier": "involved_in", "term": "ventricular septum development"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0003337", "pubmed": 8861958, "qualifier": "involved_in", "term": "mesenchymal to epithelial transition involved in metanephros morphogenesis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006351", "pubmed": 9590296, "qualifier": "involved_in", "term": "DNA-templated transcription"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006357", "qualifier": "involved_in", "term": "regulation of transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006790", "qualifier": "involved_in", "term": "sulfur compound metabolic process"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0007417", "pubmed": 15494458, "qualifier": "involved_in", "term": "central nervous system development"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0009653", "pubmed": 9590296, "qualifier": "involved_in", "term": "anatomical structure morphogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0010667", "qualifier": "involved_in", "term": "negative regulation of cardiac muscle cell apoptotic process"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0030878", "pubmed": [1337742, 15494458], "qualifier": "involved_in", "term": "thyroid gland development"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0030878", "pubmed": 9590296, "qualifier": "involved_in", "term": "thyroid gland development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0038194", "qualifier": "involved_in", "term": "thyroid-stimulating hormone signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0039003", "qualifier": "involved_in", "term": "pronephric field specification"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0042472", "qualifier": "involved_in", "term": "inner ear morphogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0042981", "qualifier": "involved_in", "term": "regulation of apoptotic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045893", "pubmed": [9388203, 15356023, 15961562], "qualifier": "involved_in", "term": "positive regulation of DNA-templated transcription"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045893", "qualifier": "involved_in", "term": "positive regulation of DNA-templated transcription"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045944", "pubmed": 9388203, "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0048793", "qualifier": "involved_in", "term": "pronephros development"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0048856", "qualifier": "involved_in", "term": "anatomical structure development"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0071371", "pubmed": 15961562, "qualifier": "involved_in", "term": "cellular response to gonadotropin stimulus"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0071599", "pubmed": 15494458, "qualifier": "involved_in", "term": "otic vesicle development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0072108", "qualifier": "involved_in", "term": "positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0072207", "pubmed": 7856737, "qualifier": "involved_in", "term": "metanephric epithelium development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0072221", "qualifier": "involved_in", "term": "metanephric distal convoluted tubule development"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0072278", "pubmed": 1337742, "qualifier": "involved_in", "term": "metanephric comma-shaped body morphogenesis"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0072284", "pubmed": 1337742, "qualifier": "involved_in", "term": "metanephric S-shaped body morphogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0072289", "qualifier": "involved_in", "term": "metanephric nephron tubule formation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0072305", "qualifier": "involved_in", "term": "negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0072307", "qualifier": "involved_in", "term": "regulation of metanephric nephron tubule epithelial cell differentiation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0090190", "qualifier": "involved_in", "term": "positive regulation of branching involved in ureteric bud morphogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1900212", "qualifier": "involved_in", "term": "negative regulation of mesenchymal cell apoptotic process involved in metanephros development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1900215", "qualifier": "involved_in", "term": "negative regulation of apoptotic process involved in metanephric collecting duct development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1900218", "qualifier": "involved_in", "term": "negative regulation of apoptotic process involved in metanephric nephron tubule development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:2000594", "qualifier": "involved_in", "term": "positive regulation of metanephric DCT cell differentiation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:2000611", "pubmed": 15356023, "qualifier": "involved_in", "term": "positive regulation of thyroid hormone generation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:2000612", "pubmed": 15356023, "qualifier": "involved_in", "term": "regulation of thyroid-stimulating hormone secretion"}], "CC": [{"evidence": "ISA", "gocategory": "CC", "id": "GO:0000785", "qualifier": "part_of", "term": "chromatin"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": [9388203, 15961562, 21317881], "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}], "MF": [{"category": "MF", "evidence": "IDA", "id": "GO:0000976", "pubmed": 15356023, "qualifier": "enables", "term": "transcription cis-regulatory region binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0000978", "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0000978", "pubmed": 9388203, "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "ISA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IEA", "id": "GO:0001228", "qualifier": "enables", "term": "DNA-binding transcription activator activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003677", "pubmed": [8861958, 15961562], "qualifier": "enables", "term": "DNA binding"}, {"category": "MF", "evidence": "IMP", "id": "GO:0003677", "pubmed": 9590296, "qualifier": "enables", "term": "DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003700", "pubmed": [9388203, 9590296], "qualifier": "enables", "term": "DNA-binding transcription factor activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0004996", "pubmed": 9590296, "qualifier": "enables", "term": "thyroid-stimulating hormone receptor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [19010321, 20195357, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:1990837", "pubmed": 28473536, "qualifier": "enables", "term": "sequence-specific double-stranded DNA binding"}]}, "homologene": {"genes": [[7955, 60637], [8364, 780226], [9544, 701906], [9598, 459503], [9606, 7849], [9913, 534661], [10090, 18510], [10116, 81819]], "id": 2589}, "interpro": [{"desc": "Paired domain", "id": "IPR001523", "short_desc": "Paired_dom"}, {"desc": "Homeobox-like domain superfamily", "id": "IPR009057", "short_desc": "Homeobox-like_sf"}, {"desc": "Paired-box protein 2 C-terminal", "id": "IPR022130", "short_desc": "Pax2_C"}, {"desc": "Winged helix-like DNA-binding domain superfamily", "id": "IPR036388", "short_desc": "WH-like_DNA-bd_sf"}, {"desc": "Paired DNA-binding domain", "id": "IPR043182", "short_desc": "PAIRED_DNA-bd_dom"}, {"desc": "PAX family", "id": "IPR043565", "short_desc": "PAX_fam"}], "ipi": ["IPI00183926", "IPI00221027", "IPI00306346", "IPI00335892", "IPI00790594"], "map_location": "2q14.1", "name": "paired box 8", "other_names": ["paired box protein Pax-8", "paired domain gene 8"], "pantherdb": {"HGNC": "8622", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "97492", "ortholog_type": "LDO", "panther_family": "PTHR45636", "taxid": 10090, "uniprot_kb": "Q00288"}, {"RGD": "620434", "ortholog_type": "LDO", "panther_family": "PTHR45636", "taxid": 10116, "uniprot_kb": "P51974"}, {"ZFIN": "ZDB-GENE-001030-3", "ortholog_type": "LDO", "panther_family": "PTHR45636", "taxid": 7955, "uniprot_kb": "F1Q9Q9"}, {"WormBase": "WBGene00013147", "ortholog_type": "LDO", "panther_family": "PTHR45636", "taxid": 6239, "uniprot_kb": "O01996"}, {"WormBase": "WBGene00003939", "ortholog_type": "O", "panther_family": "PTHR45636", "taxid": 6239, "uniprot_kb": "G5ED66"}, {"WormBase": "WBGene00001204", "ortholog_type": "O", "panther_family": "PTHR45636", "taxid": 6239, "uniprot_kb": "G5ED14"}, {"WormBase": "WBGene00003938", "ortholog_type": "O", "panther_family": "PTHR45636", "taxid": 6239, "uniprot_kb": "Q21263"}, {"FlyBase": "FBgn0036285", "ortholog_type": "O", "panther_family": "PTHR45636", "taxid": 7227, "uniprot_kb": "Q8T0M4"}, {"FlyBase": "FBgn0000625", "ortholog_type": "LDO", "panther_family": "PTHR45636", "taxid": 7227, "uniprot_kb": "Q9VTX7"}, {"FlyBase": "FBgn0005561", "ortholog_type": "O", "panther_family": "PTHR45636", "taxid": 7227, "uniprot_kb": "O16117"}, {"FlyBase": "FBgn0003130", "ortholog_type": "O", "panther_family": "PTHR45636", "taxid": 7227, "uniprot_kb": "P23758"}], "uniprot_kb": "Q06710"}, "pathway": {"kegg": [{"id": "hsa04918", "name": "Thyroid hormone synthesis - Homo sapiens (human)"}, {"id": "hsa05200", "name": "Pathways in cancer - Homo sapiens (human)"}, {"id": "hsa05202", "name": "Transcriptional misregulation in cancer - Homo sapiens (human)"}, {"id": "hsa05216", "name": "Thyroid cancer - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-9758941", "name": "Gastrulation"}, {"id": "R-HSA-9761174", "name": "Formation of intermediate mesoderm"}, {"id": "R-HSA-9830364", "name": "Formation of the nephric duct"}, {"id": "R-HSA-9830369", "name": "Kidney development"}], "wikipathways": [{"id": "WP2032", "name": "Thyroid stimulating hormone (TSH) signaling pathway"}, {"id": "WP53", "name": "ID signaling pathway"}]}, "pdb": "2K27", "pfam": ["PF00292", "PF12403"], "pharmgkb": "PA32962", "pharos": {"target_id": 14081, "tdl": "Tchem"}, "pir": ["A54429", "I53340"], "prosite": "PS51057", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF229065", "relationship": "is"}, {"id": "GNF258159", "relationship": "is"}, {"id": "GNF258160", "relationship": "is"}, {"id": "GNF258161", "relationship": "is"}, {"id": "GNF258162", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF160106", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF087107", "relationship": "is"}, {"id": "GNF087108", "relationship": "is"}, {"id": "GNF087109", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF054209", "relationship": "is"}, {"id": "GNF058992", "relationship": "is"}, {"id": "GNF074304", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF070817", "relationship": "is"}, {"id": "GNF070818", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF010888", "relationship": "is"}}, "refseq": {"genomic": ["NC_000002.12", "NC_060926.1", "NG_012384.1"], "protein": ["NP_003457.1", "NP_039246.1", "NP_039247.1", "NP_054698.1"], "rna": ["NM_003466.4", "NM_013951.3", "NM_013952.4", "NM_013953.4", "NM_013992.4"], "translation": [{"protein": "NP_003457.1", "rna": "NM_003466.4"}, {"protein": "NP_054698.1", "rna": "NM_013992.4"}, {"protein": "NP_039247.1", "rna": "NM_013953.4"}, {"protein": "NP_039246.1", "rna": "NM_013952.4"}]}, "reporter": {"HG-U133_Plus_2": ["121_at", "207921_x_at", "207923_x_at", "207924_x_at", "209552_at", "213917_at", "214528_s_at", "221990_at"], "HG-U95Av2": ["121_at", "36869_at"], "HG-U95B": "54494_at", "HTA-2_0": "TC02002222.hg.1", "HuEx-1_0": "2571608", "HuGene-1_1": "8054740", "HuGene-2_1": "16902015"}, "summary": "This gene encodes a member of the paired box (PAX) family of transcription factors. Members of this gene family typically encode proteins that contain a paired box domain, an octapeptide, and a paired-type homeodomain. This nuclear protein is involved in thyroid follicular cell development and expression of thyroid-specific genes. Mutations in this gene have been associated with thyroid dysgenesis, thyroid follicular carcinomas and atypical follicular thyroid adenomas. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Mar 2010].", "symbol": "PAX8", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1418277"}, "unigene": "Hs.469728", "uniprot": {"Swiss-Prot": "Q06710", "TrEMBL": ["A0A140TA56", "R9W7C9", "H0YJZ5", "H0YJD1", "G3V3F3", "A0A7P0T907"]}, "wikipedia": {"url_stub": "PAX8"}}